Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies

被引:64
作者
Wotton, C. J. [1 ]
Yeates, D. G. R. [1 ]
Goldacre, M. J. [1 ]
机构
[1] Univ Oxford, Unit Hlth Care Epidemiol, Dept Publ Hlth, Oxford OX3 7LF, England
关键词
Cancer; Diabetes mellitus; Record linkage; Type; 2; PANCREATIC-CANCER; ENDOMETRIAL CANCER; RISK; METAANALYSIS; DISEASE; COHORT; INSULIN;
D O I
10.1007/s00125-010-1987-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to determine the risk of cancer in people admitted to hospital for diabetes mellitus when aged 30 or older. This study involved the analysis of two statistical datasets of linked hospital and mortality data, in an area in southern England, between 1963 and 1998 (the Oxford Record Linkage Study, ORLS1) and between 1999 and 2008 (ORLS2). Rates of cancer in the diabetes cohorts were compared with rates of cancer in reference cohorts and expressed as rate ratios. The rate ratio for all cancer in people admitted to hospital with diabetes was 1.01 (95% CI 0.95-1.06, based on 15,898 people with diabetes) for the years 1963-1998; and 1.09 (1.00-1.19, based on 7,771 people with diabetes) in the years 1999-2008. In both datasets, there were significantly high rate ratios for cancers of the liver (ORLS1 and ORLS2, respectively, 2.0 [95% CI 1.4-2.9]; 2.5 [95% CI 1.3-4.3]), pancreas (2.2 [95% CI 1.8-2.7]; 3.5 [95% CI 2.5-4.8]) and uterus (1.5 [95% CI 1.0-2.2]; 2.6 [95% CI 1.4-4.5]). There were significantly low rate ratios for cancer of the prostate (0.6 [95% CI 0.5-0.7]; 0.7 [95% CI 0.5-0.9]) and non-melanoma skin cancer (0.6 [95% CI 0.5-0.8]; 0.8 [95% CI 0.6-0.96]). Diabetes mellitus was associated with an elevated risk of some site-specific cancers and a reduction of risk of others. Considering the risk in diabetes of all cancers combined, the elevation of risk, if any, is likely to be small and numerically less important than other known complications of diabetes.
引用
收藏
页码:527 / 534
页数:8
相关论文
共 35 条
[1]   Excess risk of primary liver cancer in patients with diabetes mellitus [J].
Adami, HO ;
Chow, WH ;
Nyren, O ;
Berne, C ;
Linet, MS ;
Ekbom, A ;
Wolk, A ;
McLaughlin, JK ;
Fraumeni, JF .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20) :1472-1477
[2]   CANCER RISK IN PATIENTS WITH DIABETES-MELLITUS [J].
ADAMI, HO ;
MCLAUGHLIN, J ;
EKBOM, A ;
BERNE, C ;
SILVERMAN, D ;
HACKER, D ;
PERSSON, I .
CANCER CAUSES & CONTROL, 1991, 2 (05) :307-314
[3]   The effects of vitamin D deficiency and insufficiency on the endocrine and paracrine systems [J].
Alpert, Patricia T. ;
Shaikh, Ulfat .
BIOLOGICAL RESEARCH FOR NURSING, 2007, 9 (02) :117-129
[4]   Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin [J].
Bowker, SL ;
Majumdar, SR ;
Veugelers, P ;
Johnson, JA .
DIABETES CARE, 2006, 29 (02) :254-258
[5]  
BRESLOW NE, 1987, IARC SCI PUBL, V82, P103
[6]   Type 2 diabetes mellitus and risk of non-Hodgkin lymphoma: A systematic review and meta-analysis [J].
Chao, Chun ;
Page, John H. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 168 (05) :471-480
[7]   Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: a pilot study [J].
Chuang, TY ;
Lewis, DA ;
Spandau, DF .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (03) :552-557
[8]   Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group [J].
Colhoun, H. M. .
DIABETOLOGIA, 2009, 52 (09) :1755-1765
[9]   Type 2 diabetes mellitus: a disease of the innate immune system? An update [J].
Crook, M .
DIABETIC MEDICINE, 2004, 21 (03) :203-207
[10]   No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis [J].
Dejgaard, A. ;
Lynggaard, H. ;
Rastam, J. ;
Thomsen, M. Krogsgaard .
DIABETOLOGIA, 2009, 52 (12) :2507-2512